The ESMO Targeted Anticancer Therapies (TAT) Congress 2025 is dedicated to targeted agents for the treatment of cancer and includes topics such as:
The ESMO Targeted Anticancer Therapies (TAT) Congress 2025 brings together delegates from industry, academia and governmental agencies with an interest in the development of innovative cancer therapies.
The ESMO Targeted Anticancer Therapies (TAT) Congress 2025 will be held in Paris, France on 03-05 Mar 2025.